eIF2 alpha/EIF2S1 RNAi

Product Discontinued

eIF2 alpha/EIF2S1 RNAi Summary

• Specificity: Homo sapiens eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa, mRNA
• Gene: EIF2S1

Applications/Dilutions

• Dilutions:
  • RNA Inhibition
  • RNAi sequence position
  • Western Blot
• Application Notes: This RNAi causes effective protein knockdown which has been antibody validated.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: DEPC-treated Water

Notes

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for eIF2 alpha/EIF2S1 RNAi

• eIF2 alpha
• EIF2
• EIF-2
• EIF2A
• EIF-2A
• EIF-2alpha
• EIF2S1 eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
• EIF2S1

Background

EIF2S1, also known as eIF2a, is the alpha subunit of the translation initiation factor eIF2 complex which catalyzes the first regulated step of protein synthesis initiation, promoting the binding of the initiator tRNA to 40S ribosomal subunits. The phosphorylation state of eIF2S1 controls the rate of tRNA translation. When eIF2a is not phosphorylated, translation occurs at a normal rate. However, upon phosphorylation by one of several kinases, eIF2S1 is stabilized, thus preventing the GDP/GTP exchange reaction and slowing translation. Recombinant human EIF2S1 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. RNAi are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: EIF2S1